Human Hair Keratin Hydrogels Alleviate Rebleeding after Intracerebral Hemorrhage in a Rat Model

• Published in: ACS biomaterials science & engineering Vol. 5; no. 2; pp. 1113 - 1122
• Main Authors: He, Ye, Qu, Qing, Luo, Tiantian, Gong, Yuhua, Hou, Zongkun, Deng, Jia, Xu, Yingqian, Wang, Bochu, Hao, Shilei
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 11.02.2019
• Subjects: intracerebral hemorrhage; keratin; rebleeding; hemostasis; surgery
• ISSN: 2373-9878; 2373-9878
• DOI: 10.1021/acsbiomaterials.8b01609

Surgery is an important therapeutic strategy for intracerebral hemorrhage (ICH) in the clinic and is theoretically beneficial for the outcome of ICH by decreasing hematoma, reducing nervous tissue damage, and removing harmful chemicals. However, the outcome of ICH surgery is always unsatisfactory due to postoperative rebleeding. We hypothesized that the injection of hemostatic agents in situ after aspiration surgery could immediately activate hemostasis once rebleeding occurs. Therefore, keratin hydrogels (K-gels) were easily prepared as a hemostatic material via a rehydration method and had a porous structure. Collagenase was injected into the basal lamina to mimic ICH rebleeding, and the K-gels were then injected into the same injured site after 2 h for hemostatic therapy. The hematoma volume was significantly reduced by K-gel treatment, indicating that in situ infusion of the K-gels inhibited hematoma enlargement when rebleeding occurred. Moreover, brain damage, including cell apoptosis, neuroinflammatory reactions, and neurological deficits, was also relieved after K-gel treatment. These results suggested that in situ injection of the K-gels into the hematoma area after ICH surgery improves the therapeutic outcome by stopping postoperative rebleeding. K-gels have great potential for clinical hemostatic application because of their excellent hemostatic properties and biocompatibility.